NCT02215031View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Single Rising Intravenous Doses of BI 44370 BS Solution in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

November 30, 2008

Conditions
Healthy
Interventions
DRUG

BI 44370

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY